These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 141745)

  • 1. Immunologic monitoring in carcinoma of the breast.
    Weese JL; Oldham RK; Tormey DC; Barlock AL; Morales A; Cohen MH; West WH; Herberman RB; Alford TC; Shorb PE; Tsangaris NT; Cannon GB; Dean JH; Djeu J; McCoy JL
    Surg Gynecol Obstet; 1977 Aug; 145(2):209-18. PubMed ID: 141745
    [No Abstract]   [Full Text] [Related]  

  • 2. The agarose migration inhibition technique for in vitro demonstration of cell-mediated immunity in man. A review.
    Clausen JE
    Dan Med Bull; 1975 Jul; 22(5):181-94. PubMed ID: 126141
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated immunity: relevance to ocular diseases.
    Meyers RL
    Invest Ophthalmol; 1975 Sep; 14(9):635-9. PubMed ID: 1080483
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of cellular immune response to cancer of the breast.
    Herberman RB
    Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological diagnosis of the kidney allograft rejection reaction].
    Drannik GN
    Urol Nefrol (Mosk); 1981; (5):64-71. PubMed ID: 6458144
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic problems encountered in hematology.
    Hill JM; Khan A
    Ann Allergy; 1972 Oct; 30(10):562-74. PubMed ID: 4262891
    [No Abstract]   [Full Text] [Related]  

  • 7. The fundamental and diagnostic role of T and Tn antigens in breast carcinoma at the earliest histologic stage and throughout.
    Springer GF; Desai PR; Robinson MK; Tegtmeyer H; Scanlon EF
    Prog Clin Biol Res; 1986; 204():47-70. PubMed ID: 2421349
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cellular immunity indices in benign breast tumors].
    Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
    Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cell-mediated immunological response in the light of new theories].
    Hager-Malecka B
    Pediatr Pol; 1972 Sep; 47(9):1161-6. PubMed ID: 4565188
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.
    David JR; David RR
    Prog Allergy; 1972; 16():300-449. PubMed ID: 4564107
    [No Abstract]   [Full Text] [Related]  

  • 11. Introduction: Immunotherapy of cancer in man, a reality.
    Klein E
    Natl Cancer Inst Monogr; 1973 Dec; 39():139-61. PubMed ID: 4206961
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfer factor in cellular immunity.
    Lawrence HS
    Harvey Lect; 1974; 68():239-350. PubMed ID: 4616018
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunodeficiencies in Hodgkin's disease. Part I: T cell-mediated immunity.
    Gupta S
    Clin Bull; 1981; 11(2):58-65. PubMed ID: 6459892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The assessment of cellular immunity parameters in patients with breast cancer and lymphogranulomatosis during dynamic treatment].
    Baldueva IA; Pukhova ZhK; Gavrilenkova LP; Mosberger ID
    Vopr Onkol; 1992; 38(7):787-92. PubMed ID: 1300783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte-monocyte defect associated with anergy and recurrent infections.
    Louie JS; Goldberg LS
    Clin Exp Immunol; 1972 Jul; 11(3):469-74. PubMed ID: 4625400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific lymphoblastoid cell lines: possible methods for establishment and potential application in systems of delayed hypersensitivity.
    Sondel PM; Bach FH
    Birth Defects Orig Artic Ser; 1973 Jan; 9(1):98-110. PubMed ID: 4120147
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer.
    Avigan D; Wu Z; Joyce R; Elias A; Richardson P; McDermott D; Levine J; Kennedy L; Giallombardo N; Hurley D; Gong J; Kufe D
    Bone Marrow Transplant; 2000 Jul; 26(2):169-76. PubMed ID: 10918427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic evaluation of cell-mediated immunity.
    Virella G; Patrick CC; Goust JM
    Immunol Ser; 1990; 50():303-21. PubMed ID: 2151120
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular (T cell) immunity in the human newborn.
    Stiehm ER; Winter HS; Bryson YJ
    Pediatrics; 1979 Nov; 64(5 Pt 2 Suppl):814-21. PubMed ID: 159431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Micromodification of the leukocyte adherence inhibition test for cancer patients].
    Kharkevich DD; Tabagari DZ; Savinov AIu
    Vopr Onkol; 1985; 31(7):17-21. PubMed ID: 3895734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.